These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

943 related items for PubMed ID: 16006891

  • 1. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J.
    J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [Abstract] [Full Text] [Related]

  • 2. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
    Stephenson AJ, Bosl GJ, Motzer RJ, Kattan MW, Stasi J, Bajorin DF, Sheinfeld J.
    J Clin Oncol; 2005 Apr 20; 23(12):2781-8. PubMed ID: 15837993
    [Abstract] [Full Text] [Related]

  • 3. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ, Murray N, Coppin C, Kollmannsberger C, Man A, Chi KN.
    J Urol; 2005 Dec 20; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [Abstract] [Full Text] [Related]

  • 4. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Klein EA.
    BJU Int; 2009 Nov 20; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW, Zhou FJ, Han H, Qin ZK, Yu SL, Li YH, Ye YL, Teng XY.
    Ai Zheng; 2008 Dec 20; 27(12):1302-6. PubMed ID: 19079998
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB, McDermott DW, Dock W, Bahnson E, Berry AM, Steele GS, Richie JP.
    J Urol; 2009 May 20; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [Abstract] [Full Text] [Related]

  • 10. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Bosl GJ, Motzer RJ, Bajorin DF, Stasi JP, Sheinfeld J.
    J Clin Oncol; 2007 Dec 10; 25(35):5597-602. PubMed ID: 18065732
    [Abstract] [Full Text] [Related]

  • 11. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.
    Hyams ES, Pierorazio P, Proteek O, Sroka M, Kavoussi LR, Allaf ME.
    J Urol; 2012 Feb 10; 187(2):487-92. PubMed ID: 22177913
    [Abstract] [Full Text] [Related]

  • 12. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A, Carver BS, Stasi J, Bajorin DF, Motzer RJ, Bosl GJ, Sheinfeld J.
    Cancer; 2008 Feb 15; 112(4):800-5. PubMed ID: 18172902
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
    Williams SB, Steele GS, Richie JP.
    J Urol; 2009 Dec 15; 182(6):2716-20. PubMed ID: 19836777
    [Abstract] [Full Text] [Related]

  • 15. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Tal R, Sheinfeld J.
    J Urol; 2006 Nov 15; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.
    Steiner H, Peschel R, Janetschek G, Höltl L, Berger AP, Bartsch G, Hobisch A.
    Urology; 2004 Mar 15; 63(3):550-5. PubMed ID: 15028456
    [Abstract] [Full Text] [Related]

  • 18. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A, Tavernier E, Boyle H, Meeus P, Rivoire M, Droz JP.
    BJU Int; 2010 Sep 15; 106(6):779-85. PubMed ID: 20089110
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.